According to FMI, the aspiration & biopsy needles market size is estimated to reach US$ 1,405.2 million by 2033. Over the forecast period, the market is assessed to trail at a CAGR of 6.1%. In 2023, the market is expected to reach US$ 777.29 million.
Proliferation of cancer is expected to favor demand for these needles. Further, growing preference for minimally invasive procedures is expected to catalyze market growth. Factors strengthening the future market growth include cancer awareness programs conducted by governments and global health organizations.
Radiologists and surgeons deploy biopsy needle techniques such as core-needle and fine-needle procedures or biopsy to examine anomalies at a specific spot. Unfortunately, aspiration and biopsy needles are frequently reused, raising the risk of infection during operations. The reuse of needles is discouraged by healthcare authorities and product manufacturers. Still, the practice persists, resulting in the sluggish growth of the market.
| Attributes | Details |
|---|---|
| Aspiration & Biopsy Needles Market Base Year (2022) | US$ 729 million |
| Aspiration & Biopsy Needles Market (2023) | US$ 777.29 million |
| Aspiration & Biopsy Needles Market CAGR (2017 to 2022) | 5.4% |
| Aspiration & Biopsy Needles Market CAGR (2023 to 2033) | 6.1% |
| Aspiration & Biopsy Needles Market (2033) | US$ 1,405.2 million |
| Aspiration & Biopsy Needles Market Attraction | Asia Pacific to gain momentum |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Cancer is most common in more developed locations. However, mortality is greater in less developed nations due to a lack of access to treatment facilities. Adding onto this is the lack of understanding about the benefits of early identification. Frequency of cancer in key global countries is increasing. As a result, propelling the demand for laparoscopic aspiration needles and accurate cancer detection in the future years. Overall, the aspiration and biopsy needles market is likely to rise throughout the forecast period.
Core-needle, fine-needle, and laparoscopic aspiration needles aid radiologists and surgeons in analyzing anomalies at a specific spot. Patients can, however, become infected during these treatments since they require cuts and incisions for collecting tissue samples.
Aspiration and biopsy needles are reused in certain situations, increasing the risk of infection during these operations. However, healthcare authorities or product makers do not suggest reusing some laparoscopic aspiration needles. But it is a common practice, particularly in underdeveloped nations.
Principal Consultant
Disruptive trends are expected in the business. These range from shifting supply chains to cost savings, automation, and customer emphasis. Companies that recognize industry trends and align their operations with them are expected to earn significant market share.
Emerging economies like India, China, Brazil, and Mexico are projected to offer significant growth opportunities for competitors. This can be attributed several factors like:
These emerging countries' rapid economic development and rising healthcare expenditures have enhanced access to high-quality healthcare, including cancer treatment. As a result, the global market provides fresh growth prospects for established players and new entrants.
The demand for biopsy operations is projected to rise in the future years. This can be attributed to the growing awareness among people regarding various types of malignancies. However, trained surgeons who can undertake minimally invasive biopsy techniques are in short supply.
This aspect is expected to have a greater impact in developing and impoverished areas. For example, in Sub-Saharan Africa, this is one of the biggest challenges in providing care for patients with curable cancers. There is a shortage of medical oncologists, radiation oncologists, and other cancer-related healthcare professionals.
Similarly, India has a scarcity of oncologists, radiotherapists, and surgical oncologists. Although there are 1.8 million cancer patients in the country, there is only one doctor for every 2,000 cancer patients.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In the historical period, the aspiration & biopsy needles market attained CAGR of 5.4%. By 2023, the market is expected to generate market revenue of US$ 777.29 million. Multiple factors collectively thrusted market development:
From 2023 to 2033, the market is expected to see a rise, registering a 6.1% CAGR. By the end of forecast period, the market is anticipated to attain US$ 1,405.2 million. Technological upgradations are projected to mark the forecast period growth. Mergers and acquisitions are likely to increase, and so are the innovative solutions.
Needle biopsy procedure is also forecast to observe increase in implementation. However, the looming fear of infection via these needles may hold back market growth. FMI has analyzed some key trends for future.
These aspects are projected to assist market growth over the forecast period.
| Historical CAGR (2017 to 2022) | 5.4% |
|---|---|
| Forecast CAGR (2023 to 2033) | 6.1% |
According to the Institute for Health Metrics and Evaluation (IHME), the incidence of breast cancer is expected to increase. Rising awareness among patients and healthcare professionals has increased the number of cancer cases detected throughout Asia, particularly in China and India.
In North America, the market is flourishing on account of various factors. Surge in cancer cases, research and development for better treatment options, etc., are propelling market growth. High per capita health expenditure also boosts the regional growth. In 2022, North America has acquired 34% share of aspiration and biopsy needles market. Going forward, the region is expected to fare well over the upcoming period.
However, advances in imaging technology such as computed tomography and magnetic resonance imaging are expected to limit the global aspiration & biopsy needles market. Fluid biopsy's emergence may inhibit the market growth.
People are finding it difficult to finance medical costs and choose for less invasive operations in low-income nations. These nations have just 20% of health insurance reimbursements. These are provided for procedure-related expenditures of fine-needle biopsy and core-needle biopsy in the treatment of cell carcinoma.
The occurrence of blood diseases such as leukemia and aplastic anemia in developed and developing nations is increasing. This is driving the global bone marrow aspiration and biopsy needles market forward. Inadequate infrastructure for bone marrow biopsy, on the other hand, is expected to hamper the market in underdeveloped nations in the forecast period.
| Top Segment | Market Share |
|---|---|
| Hospitals | 46% |
| Core Biopsy Needles | 58.6% |
The image-guided procedure is expected to lead the global market in the forecast period. The minimally invasive biopsy and aspiration is gaining more preference in the medical practices. As a result, the demand for the image-guided procedure is also increasing.
Increasing awareness regarding cancer and its treatment is resulting in people going for checkups more frequently. Consequently, pushing the market growth.
There are segments from the product category like biopsy needles, CNB needles, VAB needles, and aspiration needles. However, the biopsy needles segment holds a considerable share. Increasing cases of cancer and the high preference for using minimally invasive diagnostic procedures on excision biopsies are aiding the segment growth.
Cancer/ tumor segment leads in this category. The segment is likely to thrive in the forecast period. The driving factors for this growth include the growing awareness of the disease and increasing cases in the developed regions due to the lethargic lifestyle.
| Region/ Country | 2022 Value Share |
|---|---|
| North America | 34% |
| Europe | 26% |
| The United States | 25.4% |
| Germany | 7.3% |
| Japan | 9.9% |
| Countries | CAGR Value |
|---|---|
| Australia | 7.1% |
| China | 6.9% |
| India | 8.3% |
China and India are building and reconstructing their medical and healthcare space. The related markets are also expected to observe healthy growth in the forecast period with these developments. This can be attributed to the surge in chronic diseases instigated by inactive and idle lifestyle. Aspiration and biopsy needles have several applications, including drug applications and diagnostics. Increased investments for cancer diagnostics and screening programs, research, and developments are boosting the market growth.
North America acquired 34% market share and Europe acquired 26% market share. New research programs launched by governments, considering the emerging new diseases, are expected to boost market growth. Here, these needles are used by surgeons, diagnostic centers, and hospitals according to the biopsies like bone needle biopsy thyroid biopsy needle size. This is increasing the demand for aspiration & biopsy needles.
Recent Developments in the Aspiration & Biopsy Needles Market:
Similar to any other medical and healthcare market, the aspiration and biopsy market also shares the dynamic nature in the global market space. Aspiration & biopsy needles market outlook explains that the competitors in the market create new products according to the USP.
Therefore, the market revolves around segments, regions, and new distribution channels. These companies are Merit Medical Systems, Cook Group Incorporated, Olympus Corporation, Medtronic PLC, Argon Medical Devices Inc., Boston Scientific Corporation, Cardinal Health Inc., Conmed Corporation, and Inrad Inc.
Key Players in the Market
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ million for value and units for volume |
| Key Region Covered | North America; Asia Pacific; Middle East and Africa; Europe; Latin America |
| Key Countries Covered | The United States, Canada, Germany, The United Kingdom, France, Italy, NORDICS, Spain, Russia, Poland, BENELUX, China, Japan, India, ASEAN, Oceania, South Korea, Brazil, Mexico, Argentina, GCC Countries, South Africa, Northern Africa, Türkiye |
| Key Segments Covered | Product Type, Procedure, Application, End User, and Country |
| Key Companies Profiled | Merit Medical Systems; Cook Group Incorporated; Olympus Corporation; Medtronic PLC; Argon Medical Devices Inc.; Boston Scientific Corporation; Cardinal Health Inc.; Conmed Corporation; Inrad Inc. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global sales of such needles are estimated to gather US$ 777.29 million in 2023.
The global demand is forecasted to grow at 6.1% through 2033.
The net worth of the global market might reach about US$ 1,405.2 million by 2033.
34% of the global sales in 2022 made North America the dominant regional market.
Merit Medical, Cook Group, and Olympus are the key players in the present market.
1. Executive Summary | Aspiration & Biopsy Needles Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Biopsy Needles
5.3.2. Aspiration Needles
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Procedure, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure, 2023 to 2033
6.3.1. Image-guided
6.3.2. Nonimage-guided
6.4. Y-o-Y Growth Trend Analysis By Procedure, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Procedure, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals & Surgical Centres
7.3.2. Diagnostic Clinics
7.3.3. Pathology Laboratories
7.3.4. Ambulatory Care Centres
7.3.5. Research & Academic Institutes
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Procedure
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Procedure
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Procedure
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Procedure
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By Procedure
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Procedure
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Product Type
12.2.3. By Procedure
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Procedure
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product Type
13.2.3. By Procedure
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Procedure
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Procedure
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Procedure
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Procedure
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Procedure
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Procedure
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Procedure
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Procedure
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Procedure
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Procedure
16.5.2.3. By End User
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Procedure
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Procedure
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Procedure
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Procedure
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Procedure
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Procedure
16.11.2.3. By End User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Procedure
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Procedure
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Procedure
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Procedure
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Procedure
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Procedure
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Procedure
16.18.2.3. By End User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Procedure
16.19.2.3. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Procedure
16.20.2.3. By End User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Procedure
16.21.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Procedure
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Medical Systems
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Cook Group Incorporated
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Olympus Corporation
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Medtronic PLC
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Argon Medical Devices Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Boston Scientific Corporation
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Cardinal Health Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Conmed Corporation
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Abbott
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Pfizer, Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Aspiration & Biopsy Needles Market
